Business Insights

Benefits of Semantic Enrichment Across the Drug Development Pipeline

January 24, 2022

Benefits of Semantic
Semantics is the process of assigning meaning to words
and is a vital step in making unstructured scientific content
machine readable, contextualizing otherwise unstructured
information. It unlocks a host of benefits to search and
analytics which are outlined below in the context of use
cases relevant to drug discovery.

Spotlight

Ingenious Med

Ingenious Med offers usable solutions that simplify workflows. Our intuitive, physician-designed, mobile/cloud based solution and professional implementation and services teams help increase revenues, align care teams and reduce the cost of care.

OTHER WHITEPAPERS
news image

Three Challenges Facing Study Start Up and the Low-Code Solution

whitePaper | December 22, 2022

The life sciences industry has been exploring ways to accelerate the study start up process for well over a decade. The industry has long understood the value behind faster clinical trials: the sooner clinical trial results can be delivered to agencies, the sooner a new treatment can be available for patients.

Read More
news image

A Brief Synopsis of Modern Randomization Methodologies and Technologies

whitePaper | December 9, 2022

Randomized, double-blind clinical trials are the gold standard for adequate and well-controlled studies in modern times. However, prior to the late 1940s, randomization and blinding were not used in medicine and as result, bias was common.

Read More
news image

Effects Of X-Ray Inspection On Pharmaceutical Products

whitePaper | December 12, 2019

X-ray inspection of pharmaceutical products and over-the-counter (OTC) medications are steadily increasing in use as pharmaceutical manufacturers worldwide strive to safeguard their brand reputations, protect consumers' welfare and comply with national and international regulations and legislation.

Read More
news image

New technology advances biopharma chromatography productivity

whitePaper | February 16, 2023

Monoclonal antibody drugs (mAbs) make up more than 50 percent of the biologics on the market today, as well as a significant number of new drugs in the development pipeline. The value and impact of these therapies has been dramatic.

Read More
news image

The SwedishDrug Discovery and DevelopmentPipeline 2023

whitePaper | March 23, 2023

Sweden is and should remain a leading life sciences nation. The life sciences industry is one of Sweden’s economic base industries with a signifi cant share of our exports.

Read More
news image

Pharma R&D Annual Review 2023

whitePaper | April 20, 2023

Welcome to Pharmaprojects’ 2023 review of trends in pharmaceutical R&D. For over 30 years now, I’ve been taking an annual look at the evolution of pharma R&D, and in this article, I’llexamine the state of play at the start of 2023.

Read More

Spotlight

Ingenious Med

Ingenious Med offers usable solutions that simplify workflows. Our intuitive, physician-designed, mobile/cloud based solution and professional implementation and services teams help increase revenues, align care teams and reduce the cost of care.

Events